Доказательная кардиология

Falk R.H., Pollak A., Singh S.N. et al. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol 1997;29:385-390.

Norgaard B.L., Wachtell K., Christensen P.D. et al. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebocontrolled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. Am Heart J 1999;137:1062-1069.

Sedgwick M.L., Lip G., Rae A.P. et al. Chemical cardioversion of atrial fibrillation with intravenous dofetilide. Int J Cardiol 1995;49:159-166.

Torp-Pedersen C., Moller M., Bloch-Thomsen P.E. et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999;341:857-865.

Lindeboom J.E., Kingma J.H., Crijns H.J. et al. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter. Am J Cardiol 2000;85:1031-1033.

Singh S., Zoble R.G., Yellen L. et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000;102:2385-2390.

Suttorp M.J., Kingma J.H., Jessurun E.R. et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.

Borgeat A., Goy J.J., Maendly R. et al. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986;58:496-498.

Suttorp M.J., Kingma J.H., Lie A.H. et al. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.

Capucci A., Lenzi T., Boriani G. et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72.

Donovan K.D., Power B.M., Hockings B.E. et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-697.

Botto G.L., Bonini W., Broffoni T. et al. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. Pacing Clin Electrophysiol 1994;17:2114-2117.

Donovan K.D., Dobb G.J., Coombs L.J. et al. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. Am J Cardiol 1991;67:137-141.

Barranco F., Sanchez M., Rodriguez J. et al. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. Intensive Care Med 1994;20:42-44.

Baldi N., Russo V.A., Lenti V. et al. Relation between plasma levels and efficacy of flecainide and propafenone for treatment of atrial fibrillation of recent onset. New Trends Arrhythmias 1993;9:899-906.

Stambler B.S., Wood M.A., Ellenbogen K.A. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-4306.

Guo G.B., Ellenbogen K.A., Wood M.A. et al. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. J Am Coll Cardiol 1996;27:1083-1089.

Volgman A.S., Carberry P.A., Stambler B. et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-1419.

Vos M.A., Golitsyn S.R., Stangl K. et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998;79:568-575.

Stambler B.S., Wood M.A., Ellenbogen K.A. et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996;94:1613-1621.

Ellenbogen K.A., Stambler B.S., Wood M.A. et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study [published erratum appears in J Am Coll Cardiol 1996;28:1082]. J Am Coll Cardiol 1996;28:130-136.

Azpitarte J., Alvarez M., Baun O. et al. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J 1997;18:1649-1654.

Capucci A., Boriani G., Rubino I. et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994;43:305-313.

Bertini G., Conti A., Fradella G. et al. Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. J Emerg Med 1990;8:15-20.

Boriani G., Capucci A., Lenzi T. et al. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest 1995;108:355-358.

Boriani G., Biffi M., Capucci A. et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med 1997;126:621-625.

Fresco C., Proclemer A., Pavan A. et al. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, doubleblind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators. Clin Cardiol 1996;19:409-412.

Stroobandt R., Stiels B., Hoebrechts R. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. Am J Cardiol 1997;79:418-423.

Bellandi F., Cantini F., Pedone T. et al. Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study. Clin Cardiol 1995;18:631-634.

Bianconi L., Mennuni M., Lukic V. et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol 1996;28:700-706.

Weiner P., Ganam R., Ganem R. et al. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest 1994;105:1013-1016.

Di Benedetto S. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1997;80:518-519.

Vita J.A., Friedman P.L., Cantillon C. et al. Efficacy of intravenous propafenone for the acute management of atrial fibrillation. Am J Cardiol 1989;63:1275-1278.

Barroffio R., Tisi G., Guzzini F. et al. A randomised study comparing digoxin and propafenone in the treatment of recent onset atrial fibrillation. Clin Drug Invest 1995;9:277-283.

Khan I.A. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol 2001;37:542-547.

Kochiadakis G.E., Igoumenidis N.E., Solomou M.C. et al. Efficacy of amiodarone for the termination of persistent atrial fibrillation. Am J Cardiol 1999;83:58-61.

Galve E., Rius T., Ballester R. et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996;27:1079-1082.

Peuhkurinen K., Niemela M., Ylitalo A. et al. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. Am J Cardiol 2000;85:462-465.

Zehender M., Hohnloser S., Muller B. et al. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. J Am Coll Cardiol 1992;19:1054-1059.

Hou Z.Y., Chang M.S., Chen C.Y. et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J 1995;16:521-528.

Opolski G., Stanislawska J., Gorecki A. et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol 1997;20:337-340.

Noc M., Stajer D., Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 1990;65:679-680.

Tieleman R.G., Gosselink A.T., Crijns H.J. et al. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997;79:53-57.

Vardas P.E., Kochiadakis G.E., Igoumenidis N.E. et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. Chest 2000;117:1538-1545.

Nakazawa H., Lythall D.A., Noh J. et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with postthyrotoxic atrial fibrillation. Eur Heart J 2000;21:327-333.

Madrid A.H., Moro C., Marin-Huerta E. et al. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J 1993;14:1127-1131.

Kerin N.Z., Faitel K., Naini M. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs. quinidine for conversion of atrial fibrillation. Arch Intern Med 1996;156:49-53.

Hohnloser S.H., van de Loo A., Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858.

Halinen M.O., Huttunen M., Paakkinen S. et al. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). Am J Cardiol 1995;76:495-498.

Rossi M., Lown B. The use of quinidine in cardioversion. Am J Cardiol 1967;19:234-238.

Falk R.H., Knowlton A.A., Bernard S.A. et al. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 1987;106:503-506.

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Eur Heart J 1997;18:649-654.

Singh S., Saini R.K., DiMarco J. et al. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. Am J Cardiol 1991;68:1227-1230.

Sung R.J., Tan H.L., Karagounis L. et al. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Am Heart J 1995;129:739-748.

Botto G.L., Capucci A., Bonini W. et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol 1997;58:55-61.

Jordaens L. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J 1997;18:643-648.

Pilati G., Lenzi T., Trisolino G. et al. Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm. Curr Ther Res 1991;49:140-146.